Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Belinda Anderson, PhD, MA (Ed.), DAc
Dr. Belinda Anderson is associate dean and professor at Pace University in the College of Health Professions, and associate clinical professor at Albert Einstein College of Medicine. An NIH-funded researcher, her recent research has involved clinical trials implementing acupuncture in community-based clinics, educating clinicians in research and evidence-based medicine, and the use of Chinese herbs to treat COVID-19 symptoms. Dr. Anderson is a licensed acupuncturist specializing in women’s health and fertility; and is a board member of the National Certification Commission for Acupuncture and Herbal Medicine.